The Canadian Centre for Ethics in Sport (CCES) announced today that Curtis Moss, an athletics athlete, received a sanction of two months for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on June 8, 2015, revealed the presence of methylphenidate.

Methylphenidate is classified as a “specified substance” on the World Anti-Doping Agency Prohibited List. Under the rules of the Canadian Anti-Doping Program (CADP), an athlete facing a first violation involving a “specified substance” can seek to have the sanction reduced to a reprimand. Based on CCES’ assessment of the athlete’s degree of fault, the CCES proposed a sanction period of two months ineligibility.

In response to the CCES’ notification of the adverse analytical finding, Mr. Moss waived his right to a hearing, admitted the anti-doping rule violation, and accepted the proposed sanction ending January 4, 2016. The athlete, who resides in Edmonton, Alberta, is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program (CADP), including training with teammates.

In compliance with rule 7.10 of the CADP, a copy of the CCES’ reasoned decision can be found at www.cces.ca/sanctionreg.

• This media release was originally published on the Canadian Centre for Ethics in Sport’s internet site on 17 December 2015. To access the original, please click here. The direct link to the decision can be found here.